FORMER officials of the Department of Health (DOH) and Food and Drug Administration (FDA) were aware of the adverse effects of Dengvaxia vaccine because its manufacturer, Sanofi Pasteur Inc., disclosed these to them prior to the mass vaccination in 2016, documents show.
An FDA document, a certified true copy of which was obtained by The Manila Times, indicates that as early as December 2015, the vaccine maker submitted its disclosure (Responses to Question) to DOH and FDA, citing the vaccine's potential risks in particular.
